155 related articles for article (PubMed ID: 23741889)
1. Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients.
Hossain D
Lepr Rev; 2013 Mar; 84(1):105-12. PubMed ID: 23741889
[TBL] [Abstract][Full Text] [Related]
2. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
Balagon M; Saunderson PR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial.
de Barros B; Lambert SM; Shah M; Pai VV; Darlong J; Rozario BJ; Alinda MD; Sales AM; Doni S; Hagge DA; Shrestha D; Listiawan MY; Yitaye AM; Nery JAC; Neupane KD; Dias VLA; Butlin CR; Nicholls PG; Lockwood D; Walker SL
BMJ Open; 2020 Nov; 10(11):e037700. PubMed ID: 33203627
[TBL] [Abstract][Full Text] [Related]
4. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
5. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Sampaio EP; Malta AM; Sarno EN; Kaplan G
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
[TBL] [Abstract][Full Text] [Related]
6. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
7. Interventions for erythema nodosum leprosum.
Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
[TBL] [Abstract][Full Text] [Related]
8. The role of thalidomide in the management of erythema nodosum leprosum.
Walker SL; Waters MF; Lockwood DN
Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
[TBL] [Abstract][Full Text] [Related]
9. Interventions for erythema nodosum leprosum. A Cochrane review.
Van Veen NH; Lockwood DN; Van Brakel WH; Ramirez J; Richardus JH
Lepr Rev; 2009 Dec; 80(4):355-72. PubMed ID: 20306635
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide and steroid in the management of erythema nodosum leprosum.
P K Mishra SR; Samal R; Behera B
Indian J Pharmacol; 2022; 54(3):177-182. PubMed ID: 35848688
[TBL] [Abstract][Full Text] [Related]
11. A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population.
Bathula S; Sardana K; Mathachan SR; Khurana A; Ahuja A; Paliwal P
Int J Dermatol; 2023 Jan; 62(1):48-55. PubMed ID: 35924464
[TBL] [Abstract][Full Text] [Related]
12. Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study.
Girdhar A; Chakma JK; Girdhar BK
Indian J Lepr; 2002; 74(3):233-6. PubMed ID: 12708702
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of four treatment regimens in Type 2 Leprosy Reactions (Prednisolone alone, Thalidomide alone, Prednisolone plus Thalidomide and Prednisolone plus Clofazimine).
Kar HK; Gupta L
Indian J Lepr; 2016 Jan; 88(1):29-38. PubMed ID: 29741823
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Efficacy and Safety of Ciclosporin to Prednisolone in the Treatment of Erythema Nodosum Leprosum: Two Randomised, Double Blind, Controlled Pilot Studies in Ethiopia.
Lambert SM; Nigusse SD; Alembo DT; Walker SL; Nicholls PG; Idriss MH; Yamuah LK; Lockwood DN
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004149. PubMed ID: 26919207
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for erythema nodosum leprosum.
Manandhar R; LeMaster JW; Roche PW
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
[TBL] [Abstract][Full Text] [Related]
16. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy and safety of minocycline and clofazimine in chronic and recurrent erythema nodosum leprosum-A randomized clinical trial.
Hanumanthu V; Thakur V; Narang T; Dogra S
Dermatol Ther; 2021 Nov; 34(6):e15125. PubMed ID: 34490707
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
19. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
Verma KK; Srivastava P; Minz A; Verma K
Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal ocular survey of 202 Filipino patients with multi-bacillary (MB) leprosy treated with 2 year WHO-multiple drug therapy.
Ravanes JM; Cellona RV; Balagon M; Abalos RM; Walsh GP; Walsh DS
Southeast Asian J Trop Med Public Health; 2011 Mar; 42(2):323-30. PubMed ID: 21710853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
